OBJECTIVES: Animal-assisted therapy using dogs trained to be calm and provide comfort to strangers has been used as a complementary therapy for a range of medical conditions. This study was designed to evaluate the effects of brief therapy dog visits for fibromyalgia patients attending a tertiary outpatient pain management facility compared with time spent in a waiting room. DESIGN: Open label with waiting room control. SETTING: Tertiary care, university-based, outpatient pain management clinic. SUBJECTS: A convenience sample of fibromyalgia patients was obtained through advertisements posted in the clinic. INTERVENTIONS: Participants were able to spend clinic waiting time with a certified therapy dog instead of waiting in the outpatient waiting area. When the therapy dog was not available, individuals remained in the waiting area. OUTCOME MEASURES.: Self-reported pain, fatigue, and emotional distress were recorded using 11-point numeric rating scales before and after the therapy dog visit or waiting room time. RESULTS: Data were evaluated from 106 therapy dog visits and 49 waiting room controls, with no significant between-group demographic differences in participants. Average intervention duration was 12 minutes for the therapy dog visit and 17 minutes for the waiting room control. Significant improvements were reported for pain, mood, and other measures of distress among patients after the therapy dog visit, but not the waiting room control. Clinically meaningful pain relief (≥2 points pain severity reduction) occurred in 34% after the therapy dog visit and 4% in the waiting room control. Outcome was not affected by the presence of comorbid anxiety or depression. CONCLUSIONS: Brief therapy dog visits may provide a valuable complementary therapy for fibromyalgia outpatients. Wiley Periodicals, Inc.
OBJECTIVES: Animal-assisted therapy using dogs trained to be calm and provide comfort to strangers has been used as a complementary therapy for a range of medical conditions. This study was designed to evaluate the effects of brief therapy dog visits for fibromyalgiapatients attending a tertiary outpatientpain management facility compared with time spent in a waiting room. DESIGN: Open label with waiting room control. SETTING: Tertiary care, university-based, outpatientpain management clinic. SUBJECTS: A convenience sample of fibromyalgiapatients was obtained through advertisements posted in the clinic. INTERVENTIONS:Participants were able to spend clinic waiting time with a certified therapy dog instead of waiting in the outpatient waiting area. When the therapy dog was not available, individuals remained in the waiting area. OUTCOME MEASURES.: Self-reported pain, fatigue, and emotional distress were recorded using 11-point numeric rating scales before and after the therapy dog visit or waiting room time. RESULTS: Data were evaluated from 106 therapy dog visits and 49 waiting room controls, with no significant between-group demographic differences in participants. Average intervention duration was 12 minutes for the therapy dog visit and 17 minutes for the waiting room control. Significant improvements were reported for pain, mood, and other measures of distress among patients after the therapy dog visit, but not the waiting room control. Clinically meaningful pain relief (≥2 points pain severity reduction) occurred in 34% after the therapy dog visit and 4% in the waiting room control. Outcome was not affected by the presence of comorbid anxiety or depression. CONCLUSIONS: Brief therapy dog visits may provide a valuable complementary therapy for fibromyalgia outpatients. Wiley Periodicals, Inc.
Authors: Chenchen Wang; Christopher H Schmid; Ramel Rones; Robert Kalish; Janeth Yinh; Don L Goldenberg; Yoojin Lee; Timothy McAlindon Journal: N Engl J Med Date: 2010-08-19 Impact factor: 91.245
Authors: James W Carson; Kimberly M Carson; Kim D Jones; Robert M Bennett; Cheryl L Wright; Scott D Mist Journal: Pain Date: 2010-11 Impact factor: 6.961
Authors: Jaime C Branco; Bernard Bannwarth; Inmaculada Failde; Jordi Abello Carbonell; Francis Blotman; Michael Spaeth; Fernando Saraiva; Francesca Nacci; Eric Thomas; Jean-Paul Caubère; Katell Le Lay; Charles Taieb; Marco Matucci-Cerinic Journal: Semin Arthritis Rheum Date: 2009-02-27 Impact factor: 5.532
Authors: Jeffrey A Kline; Michelle A Fisher; Katherine L Pettit; Courtney T Linville; Alan M Beck Journal: PLoS One Date: 2019-01-09 Impact factor: 3.240
Authors: Maylos Rodrigo-Claverol; Carles Casanova-Gonzalvo; Belén Malla-Clua; Esther Rodrigo-Claverol; Júlia Jové-Naval; Marta Ortega-Bravo Journal: Int J Environ Res Public Health Date: 2019-08-09 Impact factor: 3.390
Authors: Kristýna Machová; Radka Procházková; Michal Říha; Ivona Svobodová Journal: Int J Environ Res Public Health Date: 2019-09-06 Impact factor: 3.390